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Abstract
Background: Elevated pregnancy hormone levels, such as oestrogen and progesterone, may
increase the risk of developing breast cancer both in mothers and offspring. However, the reasons
for large inter-individual variations in estrogen and progesterone levels during pregnancy remain
unknown. The objectives of this study were to investigate whether a) intakes of total dietary fat,
types of fat (monounsaturated: MUFA, polyunsaturated: n-3 and n-6 PUFA, and saturated) and b)
gestational weight gain are associated with estradiol and progesterone levels in plasma during
pregnancy.
Methods: We measured body weight as well as estradiol and progesterone in plasma among 226
healthy pregnant Swedish women on gestation weeks 12, 25 and 33. At the same time points,
dietary intake of total fat and types of fat (MUFA, PUFA, SFA, n-3 and n-6 PUFA) were estimated
using 3-day food diaries.
Results: A large variation in estradiol and progesterone levels was evident.
Nulliparous women had 37%, 12% and 30% higher mean estradiol levels on gestation weeks 12, 25
and 33 compared to parous women (P = 0.008). No associations were found between dietary
intake of total fat or fat subtypes (including n-3 PUFA and n-6 PUFA) and plasma estradiol or
progesterone levels. Gestational weight gain was associated with progesterone levels (P = 0.03) but
the effect was very small (20% increase in progesterone levels between gestational weeks 12 and
33 per kg body weight/week).
Conclusion: No associations among gestational weight gain, maternal dietary fat intake (total or
subtypes including n-3 PUFA and n-6 PUFA) and plasma estradiol levels were found. However,
pregnancy progesterone levels correlated with weight gain during pregnancy. Identification of other
possible determinants of pregnancy estradiol and progesterone levels, important for the
development of breast cancer in both mothers and offspring, are needed.
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Background
Low parity and late age at first full-term birth are well-
established risk factors for breast cancer in the mothers
[1]. Recently it has also become evident that the environ-
ment in utero modifies the breast cancer risk in the female
offspring. A large body of epidemiological evidence shows
that a high birth weight increases breast cancer risk [2,3].
The biological mechanisms underlying these associations
are not fully known, but variations in maternal hormone
levels during pregnancy e.g. estrogens or progesterone
have been proposed to play a role [1,4]. The estrogen-
hypothesis is supported by findings showing that preg-
nant women [5] who haven taken diethylstilbestrol (a
synthetic estrogen) exhibit increased breast cancer risk,
and the findings from a nested-case control study in
which women with higher pregnancy estrone levels dur-
ing the third trimester had a two-fold incidence of breast
cancer compared to controls [6]. Furthermore, several
studies have reported positive associations between
maternal estrogen levels and fetal size [7,8]. For progester-
one, Hispanic women who are at lower risk of breast can-
cer than Caucasian women have been reported to have the
lowest pregnancy levels of progesterone [9].
Pregnancy is characterised by a substantial increase in oes-
trogen and progesterone levels [10], and these levels also
exhibit a marked inter-individual variability during preg-
nancy [11]. The reason for this inter-individual variability
is unknown, but e.g. diet, particularly dietary fats, may be
important. Earlier studies, using animal models, indicate
that maternal consumption of a high fat diet containing
high amount of n-6 polyunsaturated fatty acids (n-6
PUFA) statistically significantly increases pregnancy estra-
diol levels [12,13] as well as the incidence of mammary
tumours in dams and offspring [12,13]. Such associations
may also exist in humans, but available data are limited.
So far only one study has been published reporting on the
associations between maternal dietary intake of n-3 and
n-6 PUFAs and pregnancy estradiol levels [14]. That study
provided some evidence supporting the animal studies
results, namely a positive association between PUFA and
umbilical cord estriol levels as well as an inverse associa-
tion between n-3 PUFA with umbilical cord estradiol lev-
els among Japanese women [14]. Dietary intake was
measured only once, on gestation week 29. No corre-
sponding data for n-3 and n-6 PUFA in relation to mater-
nal estradiol levels are available in Caucasian women who
have higher breast cancer incidence.
The inter-individual variations of pregnancy estrogen and
progesterone levels may also be explained by variations in
weight gain during pregnancy. The adipose tissue acts as
an endocrine and metabolic organ and thus influences the
synthesis and bioavailability of estrogens. Both epidemio-
logical and animal data suggest that women who gain
excessive amounts of weight during their pregnancies
have an increased breast cancer risk later in life [15,16].
However, longitudinal data regarding gestational weight
gain in relation to pregnancy hormone levels are very lim-
ited. Two studies reporting no associations between total
gestational weight gain and estriol [17,18] and estradiol
levels [18] and a weak negative association for progester-
one [18] are available, but none of these studies evaluated
weight gain and pregnancy hormone levels during the dif-
ferent trimesters of pregnancy.
We present here results from a prospective cohort study in
pregnant Swedish women whose intakes of a) total die-
tary fat, types of fat (monounsaturated: MUFA, polyunsat-
urated: n-3 and n-6 PUFA, saturated:SFA) and b)
gestational weight gain were compared to plasma estra-
diol and progesterone levels on gestation weeks 12, 25
and 33.
Methods
Subjects
Two-hundred-ninety pregnant women were recruited
from April 2000 through November 2003 before gesta-
tional week 12 at Solna maternity unit, Stockholm, as pre-
viously described [19]. These 290 women filled in a
questionnaire on gestation week 12 covering health sta-
tus, smoking and education. On gestation week 12, 25
and 33, their body weights were measured in light cloth-
ing without shoes on the scale (SECA delta, AJ Medical,
Stockholm, Sweden) and a blood sample was drawn to
estimate plasma levels of estradiol and progesterone. Fur-
thermore, pregnant women completed 3-day food diaries
on gestation weeks 12, 25 and 33. Infant birth character-
istics were obtained from medical records. Sixteen women
were lost to follow-up after the initial meeting and for the
present analysis 48 were excluded due to twin pregnancy
(n = 6) or because they had missing data on the baseline
questionnaire (n = 7) or on one of the three measure-
ments for body weight, dietary intake, estradiol or proges-
terone levels (n = 35). Thus, 226 women were included to
the present study. Average body mass index (BMI), age,
education, and parity of the 64 women who opted out of
the study or were excluded were similar to the 226 partic-
ipating women. The 226 women were healthy and had no
history of hypertension, diabetes or thyroid problems. All
women signed a written informed consent before inclu-
sion in the study. The study was approved by the ethics
committee at the Karolinska Institute (dnr 00-141).
Dietary intake
The women recorded their food intake by means of food
diaries during three consecutive days, including one week-
end day. Portion sizes of food and drinks were weighed by
the women themselves using a standard calibrated bal-
ance. The women received the food diaries and personalBMC Women's Health 2009, 9:10 http://www.biomedcentral.com/1472-6874/9/10
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instructions on how to fill in the diaries from one trained
midwife. Intake of energy, total fat, monounsaturated fat,
saturated fat, polyunsaturated fat, n-3 PUFA and n-6
PUFA, carbohydrates and protein were calculated by link-
ing reported food intake to the food composition table
from the National food administration from 2004. Aver-
age values for the three days were used. Dietary intake of
long chain n-3 PUFA was calculated as the sum of docosa-
hexaenoic acid (DHA) and eicosapentaenoic acid (EPA).
The calculations of energy and nutrients were conducted
by M Löf who is a trained nutritionist. She contacted the
women when she had problems to interpret the written
information in the diaries.
Estradiol and progesterone levels in the plasma
The plasma samples were stored at -80°C. Estradiol and
progesterone levels were assessed using the Beckman
Coulter (formerly DSL) – DSL-4400 estradiol double anti-
body kit and Siemens (formerly DPC) – TKPG2 kit,
respectively. The antibodies used have high affinity for
estradiol and progesterone, respectively, and low cross-
reactivity to other naturally-occurring hormones. In the
estradiol assay, the minimum detection limit is 10 pg/mL,
and the coefficient of variation for intra-assay replicates is
5.2% and for inter-assay duplicates 10.6%. In the proges-
terone assay, the minimum detection limit is 0.10 ng/mL,
and the coefficient of variation for intra-assay replicates is
4.1% and for inter-assay duplicates 6.4%. All plasma sam-
ples from each woman were analyzed in the same series
and performed in duplicates.
Statistical data analysis
To evaluate the study objectives a series of linear mixed
effect models were fitted. The models utilized the within-
subject measurements for the relation between estradiol
or progesterone and weight gain (kg/week) and nutrients
[total fat intake (g/day), SFA (g/day), MUFA (g(day),
PUFA (g/day), n-3 PUFA (g/day), n-6 PUFA(g/day) and
long n-3 PUFA (g/day)] at week 12, 25 and 33 while
adjusting for baseline characteristics for the variables age
at enrollment (years), BMI before pregnancy, (kg/m2),
parity (number of children before index pregnancy),
smoking (Yes/No), and education (2–3 years of secondary
school or less, non-university degree or university degree).
Total fat and subtypes of fat were energy adjusted using
the residual method [20]. Since the estradiol and proges-
terone data was right skewed and with a few high outliers
these variables were analyzed on the log scale.
Models were fitted for the analysis of the relation between
estradiol as well as progesterone and a) intake of total or
types of fat b) weight gain. Separate models were evalu-
ated for fat intake and gestational weight gain since exces-
sive gestational weight gains may result from a high
dietary fat intake but also be the consequence of eating
excessive amounts of other energy-yielding nutrients (pro-
tein or carbohydrates) or from a low physical activity.
Additionally, we fitted models where we included both fat
(total or subtypes) and weight gain. We also fitted models
with SFA+MUFA+PUFA and n-3 PUFA+n-6PUFA, respec-
tively. The fitness of the models fitted was evaluated with
respect of normality and single gross outliers utilizing
model residuals.
As an alternative approach for handling the within sub-
jects variation when analysing the baseline variables the
estradiol (or progesterone), total fat and fat subtypes were
summarized by calculating the area under the estradiol
(or progesterone), total fat and fat subtypes versus time
curve (AUC). Division of AUC by 22 weeks produced a
mean value for the whole period between gestation weeks
12 and 33 (mean area under the curve, MAUC). However,
as the results obtained using this approach were very sim-
ilar to the results from the models above we do not report
results obtained using the MAUC estimates.
We also evaluated models allowing for different effects of
the baseline characteristics at the different time points by
including an interaction term between each baseline char-
acteristic and time (gestational week 12, 25 and 33).
Statistical significance was considered at the two-sided p <
0.05 level. All statistical analyses were carried out using
the SAS software procedure Mixed for repeated measure-
ments, version 9.1.
Results
The characteristics of the 226 subjects are shown in Table
1. The measured body weights and the reported dietary
intake of total fat, SFA, MUFA, PUFA, n-3 PUFA and n-6
PUFA on gestation weeks 12, 25 and 33 are shown in
Table 2.
As expected the estradiol as well as the progesterone levels
increased substantially throughout pregnancy (Figures 1
and 2). The mean estradiol levels were 600% higher on
gestation week 25 compared to gestation week 12 (P <
0.0001) and 150% higher on gestational week 33 com-
pared to gestational week 25 (P < 0.0001). The corre-
sponding increases in progesterone were 240% from
gestational week 12 to gestational week 25 (P < 0.0001)
and 190% from gestational weeks 25 to gestational week
33 (P < 0.0001). Furthermore, also shown in Figure 1, a
large variation in estradiol and progesterone levels were
evident.
The estradiol levels were also affected by parity. The mean
estradiol levels for nulliparous women were 1826, 7327
and 11201 pg/ml on gestation weeks 12, 25 and 33,
respectively, and these figures were statistically signifi-BMC Women's Health 2009, 9:10 http://www.biomedcentral.com/1472-6874/9/10
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cantly higher than the corresponding values for parous
women: 1346, 6553 and 9532 pg/ml (P = 0.008). Proges-
terone levels were not affected by parity.
The associations between estradiol levels and weight gain,
total fat intake and fat subtypes are shown in Table 3. No
statistically significant association between weight gain or
estradiol levels was found in the univariate model or
when we adjusted for maternal age, BMI before preg-
nancy, smoking, parity and education. Correspondingly,
no statistically significant associations between estradiol
levels and total fat, SFA, PUFA, MUFA, n-3 PUFA, long n-
6 PUFA or n-6 PUFA were found in our univariate or mul-
tivariable models. Similar results were obtained when we
fitted several types of fat in the same model
(SFA+MUFA+PUFA and n-3 PUFA+n-6PUFA). Further-
more, similar results were obtained when we fitted gesta-
tional weight gain and fat (total or subtypes) intake in the
same model (data not shown).
The corresponding associations between progesterone
levels and weight gain, total fat intake and fat subtypes are
shown in Table 4. A statistically significant association
between gestational weight gain and progesterone levels
was found (P = 0.03) but the effect was small: a 1 kg/week
increase on gestation weight gain was associated with a
20% increase in progesterone levels between gestational
weeks 12 and 33. No statistically significant associations
between progesterone levels and total fat, SFA, PUFA,
MUFA, n-3 PUFA, long n-6 PUFA or n-6 PUFA were found
Table 1: Characteristics of women in the study (n = 226)
Age (years), mean ± SD (range) 32 ± 4 (22–42)
Body weight before pregnancy (kg)
mean ± SD (range) 64.9 ± 9.4 (46.0–96.0)
median (25th, 75th percentile) 63.0 (58.0–68.0)
BMI before pregnancy (kg/m2)
mean ± SD (range) 22.9 ± 3.0 (17.1–34.6)
median (25th, 75th percentile) 22.2 (20.8–24.1)
Parity, n (%)
0 150 (66%)
1 64 (28%)
2 12 (5%)
Education, n (%)
Low (two to three years secondary school or less) 72 (32%)
Medium (non-university degree) 20 (9%)
High (university degree) 134 (59%)
Smoking during pregnancy, n (%)
Yes 8 (4%)
No 218 (96%)
Birth weight of infant* (g),
mean ± SD (range) 3630 ± 510 (2420–4950)
median (25th, 75th percentile) 3630 (3330–3990)
Birth length of infant* (cm)
mean ± SD (range) 51 ± 2 (44–57)
median (25th, 75th percentile) 51 (50.0–52.0)
N, number of subjects; SD, standard deviation *51% boys, 49% girls
Table 2: Body weight and dietary fat intake at different stages of pregnancy (n = 226)*
Gestational week 12 Gestational week 25 Gestational week 33
Body weight (kg) 66.6 ± 10.0 73.3 ± 10.1 77.7 ± 10.4
Total energy (kJ/day) 8710 ± 1720 9330 ± 1740 9310 ± 1760
Total fat (g/day) 73.2 ± 21.2 81.9 ± 21.2 81.3 ± 20.8
SFA (g/day) 31.2 ± 9.9 35.0 ± 10.0 35.3 ± 10.4
MUFA (g/day) 26.3 ± 8.4 29.6 ± 8.4 28.9 ± 8.0
PUFA (g/day) 10.5 ± 3.7 11.5 ± 4.1 11.2 ± 3.9
n-3 PUFA (g/day) 1.92 ± 0.76 2.07 ± 0.93 1.97 ± 0.77
Long n-3 PUFA (g/day) 0.27 ± 0.37 0.25 ± 0.34 0.20 ± 0.27
n-6 PUFA (g/day) 8.44 ± 3.17 9.27 ± 3.49 9.07 ± 3.41
n-6 PUFA/n-3 PUFA 4.64 ± 1.36 4.92 ± 3.23 4.85 ± 1.46
*Values are means ± SDBMC Women's Health 2009, 9:10 http://www.biomedcentral.com/1472-6874/9/10
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in any of our univariate or multivariable models irrespec-
tively if we fitted the fat types in separate models or com-
bined several of them in the same model
(SFA+MUFA+PUFA and n-3 PUFA+n-6 PUFA).). Similar
results were obtained when we fitted gestational weight
gain and fat (total or subtypes) intake in the same model
(data not shown).
We also tested if total energy intake or intake of the other
energy-yielding nutrients: carbohydrate and protein were
associated with estradiol or progesterone plasma levels.
However, none of these variables were associated with
estradiol or progesterone levels (data not shown).
We found no evidence for an interaction between any of
the baseline characteristics and time of measurement (i.e.
pregnancy week when the samples were taken) and levels
of estradiol and progesterone (data not shown).
Discussion
We report here results from the first study which have
measured maternal intakes of dietary fat (including n-3
PUFA and n-6 PUFA) using food diaries in all trimesters
in relation to maternal plasma estradiol and progesterone
levels in a group of Caucasian women. No association
between dietary intakes of total fat or fat subtypes (includ-
ing n-3 PUFA and n-6 PUFA) and plasma estradiol or pro-
gesterone levels were found. Gestational weight gain was
Estradiol in plasma (pg/ml) on gestation weeks 12, 25 and 33 Figure 1
Estradiol in plasma (pg/ml) on gestation weeks 12, 25 and 33. Boxes are drawn between the 25th and 75th percentiles 
with the median rate marked as a straight line. Estradiol in plasma for the 226 individual women is shown as unfilled circles.
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not associated with plasma estradiol levels, while a posi-
tive association was found for progesterone.
To our knowledge this is the first study to evaluate n-3
PUFA and n-6 PUFA in relation to maternal progesterone
levels. Further, only one earlier study has investigated the
impact of n-3 PUFA and n-6 PUFA on pregnancy estradiol
levels. In 189 Japanese pregnant women dietary intake
was measured on gestation week 29 using a food diary
and pregnancy estrogen levels were measured on gestation
week 10 and 29. No association was found between
maternal dietary intakes of n-3 PUFA or n-6 PUFA and
serum estradiol levels. However, a positive association
between n-6 PUFA and umbilical cord estriol levels as well
as an inverse association between n-3 PUFA with umbili-
cal cord estradiol levels was found [14]. In our study, con-
ducted in a Caucasian population with a high risk of
breast cancer, did not provide any support for an oppos-
ing effect of n-3 and n-6 PUFA on pregnancy estradiol lev-
els. The somewhat inconsistent results may be due to
several reasons. First, the associations for n-3 and n-6
PUFA and estradiol in Japanese women were only
detected in umbilical cord, and we measured estradiol in
circulating plasma. Second, the populations differ in sev-
eral respects. Estradiol levels were higher in the Japanese
women, which in agreement with earlier reports compar-
ing estradiol levels in Asian and Caucasian pregnant
women [9]. Furthermore, the dietary intake of long n-3
PUFA was twice as high in the Japanese women.
Progesterone in plasma (ng/ml) on gestation weeks 12, 25 and 33 Figure 2
Progesterone in plasma (ng/ml) on gestation weeks 12, 25 and 33. Boxes are drawn between the 25th and 75th percen-
tiles with the median rate marked as a straight line. Progesterone in plasma for the 226 individual women is shown as unfilled 
circles.
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Three earlier studies have evaluated the associations
between pregnancy estradiol levels and maternal dietary
intakes of total fat, MUFA, PUFA and SFA [14,18,21], and
one of these studies also investigated the corresponding
associations for progesterone [18]. Their results are con-
sistent with our findings. The first one was conducted in
141 pregnant Greek women and the authors found no
association between pregnancy estradiol levels and mater-
nal dietary fat (total, MUFA, PUFA or SFA), measured
using a food frequency questionnaire (FFQ) in pregnancy
week 26 [21]. The second study which was conducted in
270 American women, did not find any association
between pregnancy estradiol or progesterone levels and
maternal dietary fat (total, MUFA, PUFA or SFA) esti-
mated using a FFQ either on gestation weeks 16 and 27
[18]. The third study is the Japanese study referred to
above and they also reported no association between total
fat, MUFA, PUFA or SFA and estradiol levels on gestation
week 29 [14].
To our knowledge no other study has evaluated the
impact of gestational weight gain using repeated measure-
ments of body weight during pregnancy on maternal
plasma estradiol or progesterone levels. Still, in accord-
ance to our findings, Lagiou et al reported no effect of
total gestational weight gain on estradiol levels on gesta-
tion week 16 and 27 in a group of American women [18],
and a very small effect of progesterone [18]. Furthermore,
a recent study reported no association between total preg-
nancy weight gain and maternal umbilical cord estrogen
levels [22]. Thus, although pregnancy weight gain has
been linked to an increased breast cancer risk [15,16] the
limited available data does not support a major role for
maternal estradiol levels for this association. However,
pregnancy progesterone levels were positively associated
with weight gain during pregnancy. Still, this finding
should be confirmed in other populations since we made
multiple comparisons and our finding may be due to
chance. Our animal studies indicate that other hormones
e.g. leptin may be interesting in this context [15].
Table 3: Weight gain and dietary fat (total and subtypes) in relation to plasma estradiol levels.
Univariate* Multivariable#
Percentage change in estradiol (95% CI)§ P Percentage change in estradiol (95% CI)§ P
Weight gain (per 1 kg/week) 2.0 (-14, 18) 0.808 1.8 (-14, 18) 0.824
Total fat (per 10 g/day) 0.04 (-3.7, 3.8) 0.983 0.53 (-3.1, 4.3) 0.779
MUFA (per 10 g/day) 0.81 (-7.1, 9.4) 0.845 1.9 (-6.1,10.6) 0.651
PUFA (per 5 g/day) 0.97 (-4.9, 7.2) 0.753 1.2 (-4.7, 7.5) 0.699
SFA (per 10 g/day) -2.6 (-9.0, 4.2) 0.450 -1.2 (-8.3, 5.2) 0.606
n-3 PUFA (per 1 g/day) -3.0 (-8.0, 2.2) 0.253 -3.1(-8.1, 2.2) 0.249
n-6 PUFA(per 1 g/day) -0.21 (-1.9, 1.5) 0.806 -0.18 (-1.8, 1.5) 0.834
Long n-3 PUFA (per 0.1 g/day) -0.19 (-1.6, 1.3) 0.796 -0.25(-1.7, 1.2) 0.733
n-6 PUFA/n-3PUFA (per 0.5) 0.25(-0.53,1.0) 0.532 0.33(-0.45,1.1) 0.417
*Time of measurement (week 12, 25 or 33) was included as a variable in the model
#Adjusted for the following maternal characteristics: smoking, education, parity, age and BMI before pregnancy and time of measurement 
(gestational week 12, 25 or 33).
§This was computed as (10×-1) × 100 where × is coefficient obtained from the multiple linear analyses.
Table 4: Weight gain and dietary fat (total and subtypes) versus plasma progesterone levels.
Univariate* Multivariable#
Percentage change in estradiol (95% CI)§ P Percentage change in estradiol (95% CI)§ P
Weight gain (per 1 kg/week) 22 (20, 42) 0.029 22 (20, 42) 0.030
Total fat (per 10 g/day) -3.3 (-7.5, 1.2) 0.149 -3.0 (-7.3, 1.5) 0.190
MUFA (per 10 g/day) -4.1 (-13.2, 6.0) 0.415 -3.4(-12.6,6.9) 0.505
PUFA (per 5 g/day) -1.6 (-8.5, 5.9) 0.673 -1.4 (-8.5, 6.1) 0.700
SFA (per 10 g/day) -4.7 (-12.4, 3.5) 0.245 -4.3 (-12.0, 4.1) 0.307
n-3 PUFA (per 1 g/day) -2.8 (-9.0, 3.9) 0.411 -2.8(-9.1, 3.8) 0.395
n-6 PUFA(per 1 g/day) -0.21 (-1.9, 1.5) 0.806 -0.18 (-1.8, 1.5) 0.834
Long n-3 PUFA (per 0.1 g/day) -0.19 (-1.6, 1.3) 0.796 -0.25(-1.7, 1.2) 0.733
n-6 PUFA/n-3 PUFA (per 0.5) 0.16(-0.85,1.2) 0.756 0.17(-0.8,1.2) 0.739
*Time of measurement (week 12, 25 or 33) was included as a variable in the model
#Adjusted for the following maternal characteristics: smoking, education, parity, age and BMI before pregnancy and time of measurement 
(gestational week 12, 25 or 33).
§This was computed as (10×-1) × 100 where × is coefficient obtained from the multiple linear
analyses.BMC Women's Health 2009, 9:10 http://www.biomedcentral.com/1472-6874/9/10
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Two earlier studies have reported a positive associate
between maternal alcohol intake and estradiol levels
[14,23], while another study reported no association [24].
We did not adjust for alcoholic beverages in our study,
since none of our women reported that they drank alco-
hol during pregnancy.
The strengths of our study are the prospective design and
our repeated measurements of estradiol and progesterone
levels and dietary fat intake from all three trimesters. Fur-
thermore, in comparison to earlier studies in Caucasian
women [18,21] we used food diaries to assess dietary fat
intake. The food diaries may be advantageous for our pur-
pose since they are developed to capture "current diet"
compared to food frequency questionnaires which often
estimate "usual diet" i.e. dietary habits during a longer
time period, for instance one year before the dietary
assessment. Body weight was also measured during stand-
ardised conditions. Limitations are that we cannot
exclude some misclassification of dietary fat intake due to
the fact that dietary intake was self-reported. Still such
errors are likely not associated with estradiol or progester-
one levels. Furthermore, we only measured the pregnancy
hormone estradiol, and thus we do not know if our asso-
ciations described are similar for the other estrogens such
as estriol and estrone.
Our women were not randomly recruited. However, we
have earlier concluded that this cohort is likely not very
different regarding characteristics such as gestational
weight gain and infant characteristics from other healthy
pregnant women in Sweden and other Western countries
[19]. The magnitudes of the increase in pregnancy estra-
diol and progesterone levels were also similar to earlier
reports [10], and in our study nulliparous women had
higher estradiol levels than parous women which is in
agreement with findings from other populations [25].
Furthermore, our women's diet consisted of 31%, 11%,
4.5%, 13%, 1% and 3.5% of energy from total fat, MUFA,
PUFA, SFA, n-3 PUFA and n-6 PUFA, respectively, and
these figures agree very well with a large Swedish cohort of
49 000 pre-menopausal women for total fat, MUFA,
PUFA, and SFA [26] as well as for n-3 PUFA and n-6 PUFA
(unpublished data).
Conclusion
We found no associations between gestational weight
gain, maternal dietary fat (total or subtypes including n-3
PUFA and n-6 PUFA) and plasma estradiol levels. Plasma
progesterone levels correlated with weight gain during
pregnancy. Despite earlier animal findings [12,13], cur-
rent knowledge in humans does not provide any strong
evidence for an association between pregnancy dietary fat
and pregnancy plasma estradiol levels. Identification of
other determinants of pregnancy estradiol and progester-
one levels, which have been proposed to be important for
the development of breast cancer in both mothers and off-
spring, are needed.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
EW was responsible for the recruitment and data collec-
tion, while LHC was responsible for the analyses of estra-
diol and progesterone in plasma. ML processed all food
diaries and calculated intake of energy and nutrients, pre-
pared a database with all variables as well as performed
the data analyses (in collaboration with SS who was
responsible for the statistical analyses). SA and WY con-
ducted the hormone assays. ML prepared the manuscript
which was subsequently reviewed by LHC, SS and EW. All
authors have approved the final manuscript.
Acknowledgements
We thank Siv Bramert for help with recruitment and data collection.
References
1. Britt K, Ashworth A, Smalley M: Pregnancy and the risk of breast
cancer.  Endocr Relat Cancer 2007, 14(4):907-933.
2. dos Santos Silva I, De Stavola B, McCormack V: Birth size and
breast cancer risk: re-analysis of individual participant data
from 32 studies.  PLoS Medicine 2008, 5(9):e193.
3. Lof M, Sandin S, Hilakivi-Clarke L, Weiderpass E: Birth weight in
relation to endometrial and breast cancer risks in Swedish
women.  Br J Cancer 2007, 96(1):134-136.
4. Hankinson S, Tamimi RM, Hunter D: Breast cancer.  In Textbook of
cancer epidemiology Edited by: Adami HO, Hunter D, Trichopoulos D.
New York: Oxford university press; 2008:403-445. 
5. Titus-Ernstoff L, Hatch EE, Hoover RN, Palmer J, Greenberg ER,
Ricker W, Kaufman R, Noller K, Herbst AL, Colton T, et al.: Long-
term cancer risk in women given diethylstilbestrol (DES)
during pregnancy.  Br J Cancer 2001, 84(1):126-133.
6. Peck JD, Hulka BS, Poole C, Savitz DA, Baird D, Richardson BE: Ster-
oid hormone levels during pregnancy and incidence of
maternal breast cancer.  Cancer Epidemiol Biomarkers Prev 2002,
11(4):361-368.
7. Kaijser M, Granath F, Jacobsen G, Cnattingius S, Ekbom A: Maternal
pregnancy estriol levels in relation to anamnestic and fetal
anthropometric data.  Epidemiology 2000, 11(3):315-319.
8. Mucci LA, Lagiou P, Tamimi RM, Hsieh CC, Adami HO, Trichopoulos
D: Pregnancy estriol, estradiol, progesterone and prolactin
in relation to birth weight and other birth size variables
(United States).  Cancer Causes Control 2003, 14(4):311-318.
9. Potischman N, Troisi R, Thadhani R, Hoover RN, Dodd K, Davis
WW, Sluss PM, Hsieh CC, Ballard-Barbash R: Pregnancy hormone
concentrations across ethnic groups: implications for later
cancer risk.  Cancer Epidemiol Biomarkers Prev 2005,
14(6):1514-1520.
10. Mollitch M: Hormonal changes and endocrine testing in preg-
nancy.  In Endocrinology Edited by: DeGroot L, Jameson J. Philadel-
phia: WB Saunders Company; 2001:2489-2490. 
11. Casey MLMP, Simpson ER: Pregnancy.  In Textbook of Endocrinology
Edited by: Wilson JD, Foster MD. New York: WP Saunders Co; 1992. 
12. Hilakivi-Clarke L, Clarke R, Onojafe I, Raygada M, Cho E, Lippman M:
A maternal diet high in n – 6 polyunsaturated fats alters
mammary gland development, puberty onset, and breast
cancer risk among female rat offspring.  Proc Natl Acad Sci USA
1997, 94(17):9372-9377.
13. Hilakivi-Clarke L, Onojafe I, Raygada M, Cho E, Clarke R, Lippman ME:
Breast cancer risk in rats fed a diet high in n-6 polyunsatu-
rated fatty acids during pregnancy.  J Natl Cancer Inst 1996,
88(24):1821-1827.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Women's Health 2009, 9:10 http://www.biomedcentral.com/1472-6874/9/10
Page 9 of 9
(page number not for citation purposes)
14. Nagata C, Iwasa S, Shiraki M, Sahashi Y, Shimizu H: Association of
maternal fat and alcohol intake with maternal and umbilical
hormone levels and birth weight.  Cancer Sci 2007,
98(6):869-873.
15. de Assis S, Wang M, Goel S, Foxworth A, Helferich W, Hilakivi-
Clarke L: Excessive weight gain during pregnancy increases
carcinogen-induced mammary tumorigenesis in Sprague-
Dawley and lean and obese Zucker rats.  J Nutr 2006,
136(4):998-1004.
16. Kinnunen TI, Luoto R, Gissler M, Hemminki E, Hilakivi-Clarke L:
Pregnancy weight gain and breast cancer risk.  BMC Womens
Health 2004, 4(1):7.
17. Kaijser M, Jacobsen G, Granath F, Cnattingius S, Ekbom A: Maternal
age, anthropometrics and pregnancy oestriol.  Paediatr Perinat
Epidemiol 2002, 16(2):149-153.
18. Lagiou P, Lagiou A, Samoli E, Hsieh CC, Adami HO, Trichopoulos D:
Diet during pregnancy and levels of maternal pregnancy hor-
mones in relation to the risk of breast cancer in the offspring.
Eur J Cancer Prev 2006, 15(1):20-26.
19. Lof M, Hilakivi-Clarke L, Sandin S, Weiderpass E: Effects of pre-
pregnancy physical activity and maternal BMI on gestational
weight gain and birth weight.  Acta Obstet Gynecol Scand 2008,
87(5):524-530.
20. Willett W, Howe GR, Kushi LH: Adjustment for total energy
intake in epidemiologic studies.  Am J Clin Nutr 1997,
65:1220S-1228S.
21. Petridou E, Katsouyanni K, Hsieh CC, Antsaklis A, Trichopoulos D:
Diet, pregnancy estrogens and their possible relevance to
cancer risk in the offspring.  Oncology 1992, 49(2):127-132.
22. Faupel-Badger JHRN, Potischman N, Roberts J, Troisi R: Pregnancy
weight gain is not associated with maternal or mixed umbil-
ical cord estrogen and androgen concentrations.  Cancer
Causes Control 2009, 20(2):263-7.
23. Wuu J, Hellerstein S, Lipworth L, Wide L, Xu B, Yu GP, Kuper H,
Lagiou P, Hankinson SE, Ekbom A, et al.: Correlates of pregnancy
oestrogen, progesterone and sex hormone-binding globulin
in the USA and China.  Eur J Cancer Prev 2002, 11(3):283-293.
24. Petridou E, Katsouyanni K, Spanos E, Skalkidis Y, Panagiotopoulou K,
Trichopoulos D: Pregnancy estrogens in relation to coffee and
alcohol intake.  Ann Epidemiol 1992, 2(3):241-247.
25. Arslan AA, Zeleniuch-Jacquotte A, Lukanova A, Afanasyeva Y, Katz J,
Levitz M, Del Priore G, Toniolo P: Effects of parity on pregnancy
hormonal profiles across ethnic groups with a diverse inci-
dence of breast cancer.  Cancer Epidemiol Biomarkers Prev 2006,
15(11):2123-2130.
26. Lof M, Sandin S, Lagiou P, Hilakivi-Clarke L, Trichopoulos D, Adami
HO, Weiderpass E: Dietary fat and breast cancer risk in the
Swedish women's lifestyle and health cohort.  Br J Cancer 2007,
97(11):1570-1576.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1472-6874/9/10/prepub